Equitable Trust’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.35M Sell
3,322
-114
-3% -$46.2K 0.07% 193
2025
Q1
$1.71M Sell
3,436
-47
-1% -$23.4K 0.09% 164
2024
Q4
$1.81M Sell
3,483
-100
-3% -$52K 0.1% 155
2024
Q3
$2.22M Sell
3,583
-1,428
-28% -$883K 0.14% 137
2024
Q2
$2.77M Buy
5,011
+322
+7% +$178K 0.19% 106
2024
Q1
$2.73M Buy
4,689
+355
+8% +$206K 0.19% 108
2023
Q4
$2.3M Buy
4,334
+751
+21% +$399K 0.17% 112
2023
Q3
$1.81M Sell
3,583
-105
-3% -$53.1K 0.15% 119
2023
Q2
$1.92M Sell
3,688
-1,668
-31% -$870K 0.15% 122
2023
Q1
$3.09M Sell
5,356
-345
-6% -$199K 0.24% 79
2022
Q4
$3.14M Buy
5,701
+3,135
+122% +$1.73M 0.25% 86
2022
Q3
$1.3M Hold
2,566
0.11% 150
2022
Q2
$1.39M Buy
2,566
+20
+0.8% +$10.9K 0.1% 152
2022
Q1
$1.5M Hold
2,546
0.1% 149
2021
Q4
$1.7M Hold
2,546
0.1% 149
2021
Q3
$1.46M Sell
2,546
-67
-3% -$38.3K 0.09% 152
2021
Q2
$1.32M Sell
2,613
-6,118
-70% -$3.09M 0.08% 168
2021
Q1
$3.99M Buy
8,731
+72
+0.8% +$32.9K 0.3% 93
2020
Q4
$4.03M Buy
8,659
+3
+0% +$1.4K 0.3% 93
2020
Q3
$3.82M Sell
8,656
-208
-2% -$91.8K 0.33% 79
2020
Q2
$3.21M Buy
8,864
+607
+7% +$220K 0.3% 88
2020
Q1
$2.34M Sell
8,257
-129
-2% -$36.6K 0.26% 102
2019
Q4
$2.72M Buy
8,386
+95
+1% +$30.9K 0.27% 95
2019
Q3
$2.42M Buy
8,291
+618
+8% +$180K 0.25% 97
2019
Q2
$2.25M Sell
7,673
-107
-1% -$31.4K 0.24% 101
2019
Q1
$2.13M Sell
7,780
-1,148
-13% -$314K 0.25% 97
2018
Q4
$2M Buy
8,928
+403
+5% +$90.2K 0.26% 94
2018
Q3
$2.08M Buy
8,525
+875
+11% +$214K 0.24% 105
2018
Q2
$1.58M Buy
+7,650
New +$1.58M 0.2% 115